NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
5.45
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-1647.57 Insider Own0.32% Shs Outstand1.02M Perf Week1.87%
Market Cap5.55M Forward P/E- EPS next Y- Insider Trans- Shs Float1.02M Perf Month43.42%
Enterprise Value-6.34M PEG- EPS next Q- Inst Own5.94% Short Float13.49% Perf Quarter-57.05%
Income-6.38M P/S- EPS this Y- Inst Trans0.05% Short Ratio0.09 Perf Half Y-99.10%
Sales0.00M P/B0.26 EPS next Y- ROA-44.46% Short Interest0.14M Perf YTD-99.12%
Book/sh20.86 P/C0.47 EPS next 5Y- ROE-75.14% 52W High2224.20 -99.75% Perf Year-99.67%
Cash/sh11.68 P/FCF- EPS past 3/5Y12.87% -8.46% ROIC-63.00% 52W Low3.36 62.20% Perf 3Y-99.91%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility7.02% 10.12% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM61.62% Oper. Margin- ATR (14)0.80 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.41 Sales Y/Y TTM- Profit Margin- RSI (14)43.13 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.65 EPS Q/Q111.11% SMA200.40% Beta2.12 Target Price105600.00
Payout- Debt/Eq0.00 Sales Q/Q- SMA502.24% Rel Volume0.03 Prev Close5.45
Employees55 LT Debt/Eq0.00 EarningsMay 15 BMO SMA200-98.73% Avg Volume1.52M Price5.45
IPOApr 14, 2022 Option/ShortNo / No EPS/Sales Surpr.- - Trades Volume42,480 Change0.00%
Jun-18-25 07:00AM
Jun-13-25 08:35AM
Jun-11-25 09:00AM
Jun-10-25 02:38PM
08:35AM
01:12PM Loading…
Jun-09-25 01:12PM
Jun-04-25 07:00AM
May-22-25 07:00AM
May-21-25 03:00PM
May-06-25 07:00AM
Apr-30-25 07:00AM
Apr-25-25 11:06AM
Apr-24-25 11:00AM
Mar-20-25 07:00AM
Mar-06-25 07:00AM
10:45AM Loading…
Jan-29-25 10:45AM
Jan-28-25 09:00AM
Dec-05-24 10:00AM
08:30AM
Nov-18-24 08:00AM
Oct-14-24 08:00AM
Sep-30-24 07:30AM
Sep-27-24 11:15AM
Sep-24-24 12:58PM
Sep-23-24 06:00AM
Sep-12-24 08:00AM
Jul-25-24 08:30AM
Jul-09-24 08:30AM
Jul-08-24 07:41AM
Jul-03-24 01:05PM
10:55AM Loading…
10:55AM
Jun-17-24 08:30AM
Jun-14-24 01:40PM
Jun-13-24 08:30AM
Jun-07-24 09:00AM
Jun-05-24 08:30AM
May-31-24 08:30AM
May-30-24 08:30AM
07:47AM
May-29-24 07:39AM
May-28-24 01:00PM
08:15AM
07:27AM
May-15-24 09:54AM
Apr-01-24 10:52AM
Mar-07-24 08:00AM
Feb-21-24 08:00AM
Feb-16-24 02:42PM
Jan-18-24 09:00AM
Sep-29-23 10:30AM
09:54AM
09:00AM
Sep-28-23 10:52AM
Sep-27-23 12:03PM
09:14AM
Sep-26-23 08:30AM
Sep-22-23 07:31AM
Aug-02-23 12:45PM
Jul-12-23 08:33AM
Jul-06-23 07:50AM
May-19-23 09:00AM
May-06-23 10:18AM
Apr-05-23 07:05AM
Apr-04-23 08:00AM
Mar-01-23 09:40AM
Feb-15-23 09:55AM
Feb-09-23 09:21AM
Feb-06-23 09:50AM
09:02AM
Feb-01-23 09:20AM
Jan-31-23 08:00AM
Jan-30-23 06:00AM
Jan-17-23 10:00AM
Jan-12-23 12:51PM
09:25AM
Jan-10-23 08:00AM
Jan-04-23 08:13AM
Dec-20-22 08:00AM
Dec-13-22 08:00AM
Nov-24-22 06:08AM
Nov-10-22 04:05PM
Jul-15-22 07:33AM
Jul-14-22 04:05PM
Jun-08-22 04:05PM
May-06-22 03:15PM
Apr-19-22 10:20AM
09:50AM
Apr-13-22 09:34PM
Sharps Technology, Inc. is a medical device and pharmaceutical packaging company, which engages in the development and manufacturing of innovative drug delivery systems. It also focuses on low waste, and ultra-low waste syringe technologies that incorporate both passive and active safety features. The company was founded by Alan R. Blackman and Barry B. Berler on December 16, 2017 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hayes Robert MichaelChief Executive OfficerFeb 28 '25Buy0.04175,0007,000275,882Apr 01 05:24 PM
Hayes Robert MichaelChief Executive OfficerMar 31 '25Buy0.03125,0003,750400,882Apr 01 05:24 PM
Hayes Robert MichaelChief Executive OfficerDec 04 '24Buy1.993,3006,56599,182Dec 05 06:12 PM
Hayes Robert MichaelChief Executive OfficerDec 05 '24Buy2.061,7003,507100,882Dec 05 06:12 PM